ITT0203
ITT0203
- Catalog: ITT0203
- Gene/Protein: FAM117B
- Product Description: Immunotag™ ALS2CR13 Polyclonal Antibody
385.0000
Price in reward points: 385
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | ALS2CR13 |
Clonality | Polyclonal |
Storage/Stability | -20°C/1 year |
Application | WB,ELISA |
Recommended Dilution | Western Blot: 1/500 - 1/2000. ELISA: 1/5000. Not yet tested in other applications. |
Concentration | 1 mg/ml |
Reactive Species | Human,Mouse |
Host Species | Rabbit |
Immunogen | The antiserum was produced against synthesized peptide derived from human ALS2CR13. AA range:411-460 |
Specificity | ALS2CR13 Polyclonal Antibody detects endogenous levels of ALS2CR13 protein. |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen |
Form | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Gene Name | FAM117B |
Accession No. | Q6P1L5 Q3U3E2 |
Alternate Names | FAM117B; ALS2CR13; Protein FAM117B; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein |
Description | miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part., |
Protein Expression | Human salivary gland,Kidney,Skin, |
Subcellular Localization | cytoplasm, |
Protein Function | miscellaneous:ALS2CR13 is mapped in the genomic region covering the complete candidate region for Amyotrophic lateral sclerosis 2 (ALS2).,sequence caution:Contaminating sequence. Sequence of unknown origin in the N-terminal part., |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |